Evidence map›Paper›PMID 21490060›Full record

ArticleDevelopment (Cambridge, England)2011

The Cdk4-E2f1 pathway regulates early pancreas development by targeting Pdx1+ progenitors and Ngn3+ endocrine precursors.

So Yoon Kim, Sushil G Rane

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cancers · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. E2F1 Mediates the Retinoic Acid-Induced Transcription ofMolecular and cellular biology · 2018
    Article
  13. Article
  14. Article
  15. E2F1, a Novel Regulator of Metabolism.Frontiers in endocrinology · 2017
    Review
  16. Article
  17. Article
  18. Review
  19. Notch Signaling in Pancreatic Development.International journal of molecular sciences · 2015
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

So Yoon KimRegenerative Biology Section, Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Sushil G Rane
National Institutes of Health · US

Funding

Cell Cycle Regulators in Pancreatic Development and DiseaseZIADK055105 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI RANE, SUSHIL · 2009 to 2025
$8.4M
Intramural NIH HHS
6 · The paper itself

Abstract

Cell division and cell differentiation are intricately regulated processes vital to organ development. Cyclin-dependent kinases (Cdks) are master regulators of the cell cycle that orchestrate the cell division and differentiation programs. Cdk1 is essential to drive cell division and is required for the first embryonic divisions, whereas Cdks 2, 4 and 6 are dispensable for organogenesis but vital for tissue-specific cell development. Here, we illustrate an important role for Cdk4 in regulating early pancreas development. Pancreatic development involves extensive morphogenesis, proliferation and differentiation of the epithelium to give rise to the distinct cell lineages of the adult pancreas. The cell cycle molecules that specify lineage commitment within the early pancreas are unknown. We show that Cdk4 and its downstream transcription factor E2f1 regulate mouse pancreas development prior to and during the secondary transition. Cdk4 deficiency reduces embryonic pancreas size owing to impaired mesenchyme development and fewer Pdx1(+) pancreatic progenitor cells. Expression of activated Cdk4(R24C) kinase leads to increased Nkx2.2(+) and Nkx6.1(+) cells and a rise in the number and proliferation of Ngn3(+) endocrine precursors, resulting in expansion of the β cell lineage. We show that E2f1 binds and activates the Ngn3 promoter to modulate Ngn3 expression levels in the embryonic pancreas in a Cdk4-dependent manner. These results suggest that Cdk4 promotes β cell development by directing E2f1-mediated activation of Ngn3 and increasing the pool of endocrine precursors, and identify Cdk4 as an important regulator of early pancreas development that modulates the proliferation potential of pancreatic progenitors and endocrine precursors.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCell CountCell DifferentiationCell LineageCell ProliferationCyclin-Dependent Kinase 4E2F1 Transcription FactorEmbryonic Stem CellsFemaleGene Expression Regulation, DevelopmentalHomeobox Protein Nkx-2.2Homeodomain ProteinsInsulin-Secreting CellsMaleMiceBasic Helix-Loop-Helix ProteinsCdk4 protein, mouseCyclin-Dependent Kinase 4E2f1 protein, mouseE2F1 Transcription FactorHomeobox Protein Nkx-2.2Homeodomain ProteinsNerve Tissue ProteinsNeurog3 protein, mouseNkx2-2 protein, mousepancreatic and duodenal homeobox 1 proteinTrans-Activators

Identifiers

PMID21490060
PMCPMC3082297
OpenAlexW2152528416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.